Clinical Trial Update: Apheresis of Patients With Immunodeficiency

View source ↗

Summary

An NCI-sponsored clinical trial evaluating apheresis in patients with immunodeficiencies including leukocyte adhesion deficiency type 1, DOCK8 deficiency, and G…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dock8 Deficiency
• Gata2 Deficiency
• Leukocyte Adhesion Deficiency Type

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: LAD-1, DOCK8 | Status: RECRUITING